Medical devices, healthcare technology and the business of care
510(k) clearance · K262813

InkSpace Imaging Small Body Array (SBA12PH15x)

Inkspace Imaging, Inc. · Decision date Oct 5, 2026

MEDTECHLEDGER EXPLANATIONK262813

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for K262813 on 2026-10-05, clearing the InkSpace Imaging Small Body Array (SBA12PH15x) under regulation 892.1000, product code MOS, classification name "Coil, Magnetic Resonance, Specialty." The applicant is Inkspace Imaging, Inc. of Pleasanton, California; the submission was received 08/07/2026 and handled as a Special review by the Radiology panel. SESE denotes 510(k) clearance, not premarket approval of a new device system.

The record identifies the cleared item as a specialty magnetic resonance coil intended for small-body imaging, but the public summary does not state the predicate device, the specific components or design changes assessed, or any performance data supporting equivalence. Field strength compatibility, clinical indications, and labeling terms are likewise absent from the available text and should be confirmed in the clearance letter and device labeling rather than inferred here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 5, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262813
Regulatory pathway
510(k) premarket notification
Product code
MOS
Decision code
SESE
Decision date
Oct 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Coil, Magnetic Resonance, Specialty.

Product code
MOS
FDA device class
2

FDA decision timeline

  1. K262813 received

    Application receipt date recorded by FDA.

  2. K262813 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Inkspace Imaging, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Pleasanton, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records